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INTRODUCTION

Methods
ment it has been shown recently that day 5 or day 6
Transfer could be done in all patients. The positive ␤-human chorionic gonadotropin rate in the zona intact group was blastocyst transfers using serum-free culture systems 50% (11/22) and in the zona-manipulated group was 70.8% improve the implantation rates in IVF programs (3) (4) (5) , (17/24 to the study.
Patients were randomized by using a random table was utilized. In both stages propanediol-based freezing kit was used (freeze kit 1). On day 3, the medium and two groups were formed. The first group included zona intact blastocyst transfer patients (group A, n ϭ was changed to S2 medium, and until the transfer S2 medium was used. Medium was freshened every 24 22) and the second group included zona free blastocyst transfer patients (group B, n ϭ 24). All the cycles in hr. Embryos were assessed for blastocyst development in the morning of day 5 post-ICSI. Blastocoel formathe study were down-regulated by using a long protocol gonadotropin-releasing hormone agonist (GnRHa)-tion, expansion, zona thinning, hatching, and cell structure and distribution of trophoectoderm were doc-800 g nafarelin (Synarel, Abdi Ibrahim, Turkey) nasal spray-or 1 mg leuprolide acetate (Lucrin, Abbot, umented. Full expansion, zona thinning, hatching, and well-defined borders and homogeneous distribution of Turkey) subcutaneous injections started in the luteal phase of the preceding cycle day 21. The dose was trophoectoderm cells were accepted as favorable signs.
In two patients blastocyst transfer was done on day halved when the pituitary suppression was documented by E2 levels Ͻ 50 pg/ml and absence of an ovarian cyst 5 (PM ) and in the remaining patients (n ϭ 44) transfer was done on day 6 (AM ). Up to four (in cases with on transvaginal ultrasound examination. Then ovarian stimulation was achieved by step-down administration previous multiple implantation failures) but usually two or three blastocysts were transferred. Excess blasof pure follicle-stimulating hormone (FSH) (Metrodin, Serono, Istanbul, or Follegon Organon, Istanbul, Turtocysts were cryopreserved by using a glycerol-based freezing kit (freeze kit 2) in 15 patients. All the transkey); the starting dose ranged between 150 and 600 IU daily. To trigger the final follicular maturation before fers were done by using S2 medium and Frydman transfer catheter (CCD, ref.
No. 1307000, France). In oocyte collection, 5000-10000 IU of human chrorionic gonadotropin (hCG) (Pregnyl, Organon, Turkey) was group B, blastocysts were exposed briefly (30 sec to 3 min) to 0.2% pronase (Sigma Chemical Co. P 8811) administered to each patient when there were at least three follicles Ͼ15 mm in diameter. Oocytes were in Gamete-100 medium droplets under Ovoil-150. During this time period embryos were kept in an recovered transvaginally with ultrasound guidance 35-36 hr after the hCG injection under intravenous humidified atmosphere of 5% CO 2 in air on the heated table of a K system laminar airflow hood (L-26, Knudtotal anesthesia with Propofol (Zeneca, Istanbul, Turkey). Luteal phase support was provided by 400 mg sen, Denmark) and were checked every 20-30 sec with a stereozoom microscope (Olympus SZ 1610); micronized progesterone transvaginal (Utrogestane, Laboratory, Besins Iscovesco, France) daily. In all zona softening and the beginning of the disappearance of zona were recorded. Just before the complete disapcycles intracytoplasmic injection of ejaculated spermatozoa was used as there was a male component in the pearance of zona, embryos were transferred gently and washed twice in the Gamete-100 droplets under Ovoiletiology of infertility in all couples.
For all the steps of gamete and embryo handling 150 located in the same dish. Following the zona manipulation embryos were incubated in S2 medium and culture, a spectrum of commercial media obtained from Scandinavian IVF Science Company, Sweden, for an extra 30-60 min before the transfer. Two days after the embryo transfer, E2 level was was used and no serum was added in any step. All oocytes were incubated singly, before and after intracymeasured in all patients; if the E2 level was below 2500 pmole/liter, 2000-5000 IU single-dose HCG toplasmic sperm injection (ICSI), in 50-l droplets of IVF-50, under Ovoil-150. The ICSI procedure was administration was performed. More than 25 mIU/ml ␤-hCG serum level was considered a positive pregperformed 2-3 hr after oocyte recovery. Before the ICSI procedure oocytes were denuded by using hyalnancy test on day 11 or later after the transfer. Presence of gestational sac with embryonal pole with or without uronidase solution prepared from Hyase-10X. After ICSI, oocytes were incubated at 37ЊC and a humidified fetal heartbeat was considered as a clinical pregnancy. Abortion before clinical stage was considered to be a atmosphere of 5% CO 2 in air in Heraus incubators (6220 and BB16 models, Germany).
biochemical abortion and after this stage as a clinical abortion; viable pregnancies were those that reached Fertilization was assessed 16-19 hr after ICSI procedure and culture was continued in IV-50 medium beyond 12 weeks of gestation and continuing on were considered to be ongoing pregnancies. Statistical analdroplets under Ovoil-150 until day 3. In two cases (one in group A and one in group B) (PN) stage freezing was ysis was achieved by using SPSS for MS Windows program and independent samples t test or 2 test were performed. On day 2, embryos were graded at the 2-to 4-cell stage and in four cases (three in group A and used where appropriate. P value Ͻ 0.05 was considered to be statistically significant. one in group B) day 2 freezing of some of the embryos formed embryos were transferred) in four patients, and no pregnancy was obtained in this group. Another way A (36.4%) and seven patients in group B (29.2%) had at least one previous failed IVF attempt. Transfer was of saying this is that in 20 out of 24 patients in group B there was at least one good quality, fully expanded, done on day 6 (AM ) in 44 patients, whereas in 2 patients transfer was performed on day 5 (PM ). Although pregzona-thinned embryo and 17 of these (85%) became pregnant. On the other hand, in group A in all patients nancy, implantation, and ongoing pregnancy rates are higher in group B (zona-manipulated group) there was there was at least one good quality blastocyst available for the transfer. In 15 patients (32.6%) (nine in group no statistically significant difference in terms of these variables between the two groups (Table II) . No triplet A, six in group B) there were excess blastocysts for cryopreservation. pregnancy was obtained in either group, and four twin to Gardner and Lane (11), the reasons for this inability b Day 3 of previous cycle. c NS, not significant.
DISCUSSION
to maintain the viability of the human embryo are twofold. First, most culture media that are used are zona, hatching, and subsequent implantation problems.
On the other hand, in a recent study by Gardner et al. too simple and lack some of the most important regulators of mammalian embryo development such as amino (13) very high implantation and clinical pregnancy rates were achieved in a selected group of patients acids. Second, attempts to optimize culture conditions have focused on the formulation of a single medium with the use of sequential modified culture media formulations (G 1.2 and G 2.2). Another interesting aspect for the entire preimplantation period. Such an approach does not take into account the changing physiology of this study is the presence of the very high clinical pregnancy rate in the day-3 transfer group (66%), and energy metabolism of the embryo as it develops from the zygote to the blastocyst stage, and that the which may be another indicator of improved culture conditions. In this study the authors did not use any requirements of each stage differ markedly from each other. The development of two sequential serum-free enzymatic manipulation of blastocyst zona but they performed selective assisted hatching of day-3 media formulated for the culture of human zygotes to the blastocyst stage made a considerable contribution embryos. With day 5 transfer they reported 50% implantation and 71% clinical pregnancy rate. to human IVF. On the other hand, there also were other efforts to improve the implantation rates achieved by Although these figures are astonishing, it is still possible to speculate that enzymatic zona treatment may the blastocyst stage transfers, one of which is enzymatic treatment of zona of blastocysts. The first pregfurther increase the implantation rate even up to 60%, which was achieved previously in an in vivo study nancy that was obtained by the transfer of blastocysts with zona completely removed with pronase was (10) . Supporting this speculation, in the study of Fong et al. (6) , the in vitro implantation of zona-free blastoreported by Fong et al. in 1997 (12) . After this report two series were reported (5,6) where zona-manipulated cysts on a variety of feeder monolayers was found to be 92%. In our study in group B when there was at blastocysts were transferred and high implantation rates were achieved.
least one good quality blastocyst for the transfer the pregnancy rate was found to be 85% (17/20), clinical When we looked at the data retrospectively in our IVF program, implantation rate obtained in the patients pregnancy rate was 75% (15/20), and ongoing pregnancy rate was 55% (11/20). These figures also support who had more than five embryos available and had been transferred on day 3 was found to be 14% (unpubthe importance of availability of high-quality blastocysts for the transfer, and of course this is mostly lished data). In our study in group A, implantation rate was 19% and in group B it was 24% when we consider related to the improved culture conditions. It can be concluded that blastocyst stage transfer, the two groups together the implantation rate was 21.6%. These values can be considered more optimistic at least in a selected group of patients (good responders) can increase implantation and pregnancy rates; than the value (14%) that we have obtained before. However, as these values cannot be comparable to and even with only a single good quality blastocyststage embryo transfer very high pregnancy rates can document the presence of any statistically significant difference between day 3 and days 5 or 6 transfers, a be achieved in the near future without the risk of multiple pregnancy. Enzymatic treatment of zona pelprospective randomized study is currently being performed in our center. In the study of Jones et al. (5) lucida appears to not alter the pregnancy and implantation rates, but further studies with larger group of and Scholtes and Zeilmaker (3) very similar implantation and pregnancy rates to our study were reported patients are necessary to clarify the real effect of this zona manipulation on pregnancy outcome. Improvewith day-5 and day-6 embryo transfers. In the study of Scholtes and Zeilmaker (3) embryos were transments in the culture systems will most probably bring the blastocyst stage transfers to routine use in all ferred as zona intact on day 5, whereas in the study of Jones et al. (5) , only zona-manipulated blastocysts patients in the near future; we also can expect important developments in preimplantation genetic diagnoses both on days 5 or 6 were transferred. Again, in a very recently published study, Fong et al. (6) reported 33% with the availability of more blastocyst-stage embryos and an extended study period of diagnostic procedures implantation and 53% clinical pregnancy rates, and they used a very similar embryo culture protocol to after the biopsies. us. However, they performed only zona-manipulated transfers in a selected group of patients. The success REFERENCES rates obtained in the Fong et al. (6) study also are comparable with group B in our study. When we
